Influenza Diagnostics Market - Size, Share, Outlook, and Opportunity Analysis, 2018- 2026 Global Influenza Diagnostics Market, by Test Type (Traditional Diagnostic Test and Molecular Diagnostic Assays), by End User (Hospitals and Clinics, Reference Laboratories, and Others), and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018- 2026 Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/2414 Influenza (flu) is a contagious disease of the upper respiratory system caused due to influenza virus. The two types of influenza are seasonal and pandemic. There are three main types of seasonal influenza, namely influenza A, B, and C. It is transmitted from public places through sneeze and droplets of infected person who serve as a carrier of the disease. According to the Centers for Disease Control and Prevention (CDC), in U.S. Influenza resulted in 49,000,000 symptomatic illnesses and 79,000 deaths in 2017-2018. High risk of influenza infection is observed in pregnant women, pediatrics, geriatrics, patients with low immunity that suffer from chronic illness, and healthcare professionals. Influenza Diagnostic Market – Dynamics High prevalence of influenza and increasing research funding for influenza diagnostics are major factors that are expected to drive the market growth over the forecast period. According to the World Health Organization (WHO), influenza is expected to result in around 3 to 5 million cases of severe illness and around 290,000 to 650,000 deaths in 2018 worldwide. In 2014, National Institute of Allergy and Infectious Disease (NIAID) collaborated with The National Institutes of Health (NIH) Autoimmune Disease Coordinating Committee (ADCC) and supports The Center of Excellence in Influenza Research and Surveillance (CIERS) to advance the understanding of influenza virus. High geriatric population prone to influenza, increasing awareness about the disease along with high demand for advanced and more efficient influenza diagnostic tests are expected to drive growth of the influenza diagnostics market. Influenza Diagnostic Market – Regional insights North America accounted for the largest market share in the global influenza diagnostics market. This is owing to robust initiatives of CDC toward controlling the spread of the disease by actively implementing preventive measures and recognizing the disease through its National Influenza Surveillance System. Increasing availability of Rapid Diagnostic Tests (RDTs) in the U.S. has further boosted these implementations. Asia Pacific is expected to witness rapid growth in the market during the forecast period, owing to actively participation of countries for preventive measures to counter the incidence of the influenza. For instance, in 2014 CDC funds nine non-researchedrelated bilateral influenza cooperative agreement in South-East Asian Region (SEAR), as a measure to respond to avian, seasonal, and pandemic influenza. Report includes chapters which deeply display the following deliverable about industry : • Influenza Diagnostics Market Research Objective and Assumption • Influenza Diagnostics Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Influenza Diagnostics Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Influenza Diagnostics Market, By Regions • Influenza Diagnostics Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Influenza Diagnostics Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Influenza Diagnostics Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Influenza Diagnostics Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Influenza Diagnostic Market – Competitive landscape Major players operating in the global influenza diagnostic market include, Roche Diagnostics, Becton, Dickinson and Company, Thermo Fisher Scientific, Alere, Quidel Corporation, and others. Key players in the market are focused on research and development activities in order to offer diagnostic devices that are cost-effective and efficient. For instance, in 2016, Roche received the U.S. FDA clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver for its cobas Influenza A/B & RSV test. The test is used with the cobas Liat system and assists in molecular testing of flu A/B and RSV. Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/ongoing-insight/influenza-diagnostics-market-2414 Influenza Diagnostic Market Taxonomy: On the basis of test type, the global influenza diagnostic market is segmented into: Traditional Diagnostic Tests Rapid Influenza Diagnostic Tests (RIDT) ,Viral Culture ,Direct Fluorescent Antibody (DFA) Tests ,Serological Assays Molecular Diagnostic Assays RT-PCR ,Nucleic Acid Sequence-Based Amplification (NASBA) Tests ,Loop-Mediated Isothermal Amplification-Based Assays (LAMP) ,Simple Amplification-Based Assays (SAMBA) ,Others On the basis of end user, the global influenza diagnostic market is segmented into: Hospitals & Clinics ,Reference Laboratories ,Others About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected]
High prevalence of influenza and increasing research funding for influenza diagnostics are major factors that are expected to drive the market growth over the forecast period.
© Copyright 2024 Paperzz
